Product Information
RIZATRIPTAN 5 MG TABLET is a generic product labeled by Ascend Laboratories, LLC, priced at $0.3446 per EA under NDC 67877026118. Its NADAC has been published 523 times since Aug 17, 2016.
FDA first approved this application on Feb 18, 2016. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
5 mg/1
Manufacturer
Ascend Laboratories, LLCNDC
67877026118
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
RIZATRIPTAN BENZOATEApproval Type
Generic (ANDA)
FDA Application
ANDA203269FDA Approved
2/18/2016
TE Code
AB
On Market Since
6/25/2012
Pharmacological Classes
Price Statistics
The NADAC for RIZATRIPTAN 5 MG TABLET has been published 523 times since Aug 17, 2016, and over the history we have for it it has declined 72.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3446 per EA |
|---|---|
| All-time high | $1.2600 (Sep 14, 2016) |
| All-time low | $0.3203 (Jul 17, 2024) |
| 52-week high | $0.5666 |
| 52-week low | $0.3446 |
| Median price | $0.7114 |
| Average price | $0.7029 |
| Largest weekly change | +74.4% (Aug 21, 2024) |
| Weeks tracked | 523 |
| Tracking since | Aug 17, 2016 |
Generic Alternatives
The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 7% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of RIZATRIPTAN 5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for RIZATRIPTAN 5 MG TABLET, manufactured by Ascend Laboratories, LLC, is $0.3446 per EA (NDC 67877026118), effective Aug 19, 2026.
How has the price of RIZATRIPTAN 5 MG TABLET changed over time?
Over the history we have for it, the NADAC for RIZATRIPTAN 5 MG TABLET has declined 72.7%. It has been tracked across 523 weekly CMS publications since Aug 17, 2016.
What are the highest and lowest recorded NADAC prices for RIZATRIPTAN 5 MG TABLET?
Since Aug 17, 2016, the NADAC for RIZATRIPTAN 5 MG TABLET has ranged from a low of $0.3203 (Jul 17, 2024) to a high of $1.2600 (Sep 14, 2016), with a median of $0.7114 per EA.
Are there cheaper alternatives to RIZATRIPTAN 5 MG TABLET?
Yes. 6 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, RIZATRIPTAN 5 MG TABLET, is $0.3203 per EA — about 7% below RIZATRIPTAN 5 MG TABLET.
Who manufactures RIZATRIPTAN 5 MG TABLET?
RIZATRIPTAN 5 MG TABLET (NDC 67877026118) is labeled by Ascend Laboratories, LLC, and CMS classifies it as a generic product.